Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study

B. Porter, John; Galanello, Renzo; Saglio, Giuseppe; J. Neufeld, Ellis; Vichinsky, Elliott; Domenica Cappellini, Maria; F. Olivieri, Nancy; Piga, Antonio; J. Cunningham, Melody; Soulières, Denis; Gattermann, Norbert; Tchernia, G; Maertens, Johan; J. Giardina, Patricia; L. Kwiatkowski, Janet; Quarta, Giovanni; Jeng, Michael; Luca Forni, Gian; Stadler, Michael; Cario, Holger; Debusscher, Louisette; Giovanni Della Porta, Matteo; Cazzola, Mario; L. Greenberg, Peter; Alimena, Giuliana; Rabault, B.; Gathmann, Insa; Ford, J.; Alberti, Daniele; Rosé, Christian

doi:10.1111/j.1600-0609.2007.00985.x

Public

Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study

Published in European Journal Of Haematology • Nov 20, 2007

Authors:

John B. Porter

Renzo Galanello

Giuseppe Saglio

Abstract

OBJECTIVES/METHODS: This 1-yr prospective phase II trial evaluated the efficacy of deferasirox in regularly transfused patients aged 3-81 yrs with myelodysplastic syndromes (MDS; n = 47), Diamond-Blackfan anaemia (DBA; n = 30), other rare anaemias (n = 22) or beta-thalassaemia (n = 85). Dosage was d...

Subject

Deferasirox

Medicine

Myelodysplastic syndromes

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!